• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Imlifidase
Date Designated:  07/03/2018
Orphan Designation:  Treatment of anti-glomerular basement membrane (anti-GBM) disease
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Hansa Medical AB
Scheelevägen 22, P. O. Box 785
SE-220 07

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.